You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Axitinib

Showing 1 - 25 of 221
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Advanced Solid Tumors Trial (INCB099280, axitinib)

Not yet recruiting
  • Advanced Solid Tumors
  • (no location specified)
Jul 18, 2023

Renal Cancer, Kidney Cancer, Renal Cell Carcinoma Trial in Aurora (Axitinib, Pembrolizumab)

Not yet recruiting
  • Renal Cancer
  • +3 more
  • Aurora, Colorado
    University of Colorado Cancer Center
Jul 24, 2023

Renal Cell Carcinoma, First-line Treatment, Non Clear Cell Renal Cell Carcinoma Trial in Chengdu (AK104, Axitinib)

Not yet recruiting
  • Renal Cell Carcinoma
  • +3 more
  • Chengdu, Sichuan, China
    West China Hospital
Apr 10, 2023

Renal Cell Carcinoma, Neoadjuvant Trial (Axitinib plus Toripalimab, radical nephrectomy)

Not yet recruiting
  • Renal Cell Carcinoma
  • Neoadjuvant
  • Axitinib plus Toripalimab
  • radical nephrectomy
  • (no location specified)
Feb 12, 2023

Renal Cell Carcinoma Trial in Beijing, Seoul (RO7247669, Tiragolumab, Pembrolizumab)

Recruiting
  • Renal Cell Carcinoma
  • Beijing, China
  • +1 more
Mar 28, 2023

Breast Cancer, Ovarian Cancer, Breast Tumors Trial in Dnipro, Kyiv (Axitinib)

Enrolling by invitation
  • Breast Cancer
  • +7 more
  • Axitinib
  • Dnipro, Ukraine
  • +1 more
Jun 17, 2023

Axitinib Dose Reduction and Interruption for Adverse Event

Completed
  • Renal Cell Carcinoma
  • Axitinib
  • +2 more
  • New York, New York
    Pfizer
Sep 15, 2022

Metastatic and/or Advanced Renal Cell Carcinoma, Treated With

Completed
Has Results
  • Carcinoma
  • Renal Cell
  • London, United Kingdom
    Pfizer UK
Jan 9, 2023

Japanese RCC Patients Treated With Avelumab Plus Axitinib as

Not yet recruiting
  • Renal Cell Carcinoma
  • (no location specified)
Jan 18, 2023

Alveolar Soft Part Sarcoma, Soft Tissue Sarcomas Trial in Miami (Axitinib, Pembrolizumab)

Active, not recruiting
Has Results
  • Alveolar Soft Part Sarcoma
  • Soft Tissue Sarcomas
  • Miami, Florida
    University of Miami
Dec 29, 2022

Melanoma Trial in Tampa (Ipilimumab, Axitinib)

Recruiting
  • Melanoma
  • Tampa, Florida
    Moffitt Cancer Center
Jun 21, 2022

Renal Cell Cancer Trial (Axitinib, Pembrolizumab)

Withdrawn
  • Renal Cell Cancer
  • (no location specified)
Jul 29, 2022

Pheochromocytoma, Paraganglioma Trial in New York (Axitinib)

Recruiting
  • Pheochromocytoma
  • Paraganglioma
  • Axitinib
  • New York, New York
    Columbia University Irving Medical Center
Oct 5, 2022

NSCLC Trial in Nanchang, Shanghai (KN046 plus Axitinib)

Recruiting
  • NSCLC
  • KN046 plus Axitinib
  • Nanchang, Jiangxi, China
  • +1 more
Aug 27, 2023

Kidney Cancer Trial in Houston (Axitinib)

Active, not recruiting
Has Results
  • Kidney Cancer
  • Axitinib
  • Houston, Texas
    University of Texas MD Anderson Cancer Center
Sep 2, 2022

Recurrent or Metastatic NPC Trial in Hong Kong (Axitinib, Avelumab)

Recruiting
  • Recurrent or Metastatic NPC
  • Hong Kong, Hong Kong
    Department of Clinical Oncology, Prince of Wales Hospital, The C
Jul 18, 2022

Clear Cell Renal Cell Carcinoma, Clear Cell Renal Cell Carcinoma Metastatic Trial in Iowa City (Selenomethionine (SLM),

Recruiting
  • Clear Cell Renal Cell Carcinoma
  • Clear Cell Renal Cell Carcinoma Metastatic
  • Selenomethionine (SLM)
  • +2 more
  • Iowa City, Iowa
    University of Iowa Hospitals & Clinics
Sep 19, 2022

Clear Cell Kidney Cancer, Kidney Cancer, Kidney Cancer With PBRM1/BAP1/VHL/SETD2 Mutations Trial (Axitinib 5 MG)

Available
  • Clear Cell Kidney Cancer
  • +2 more
  • Axitinib 5 MG
  • (no location specified)
Jul 3, 2023

Mucosal Melanoma Trial in New York (Nivolumab and/or Ipilimumab, Stereotactic Body Radiation Therapy (SBRT), axitinib)

Recruiting
  • Mucosal Melanoma
  • Nivolumab and/or Ipilimumab
  • +2 more
  • New York, New York
    Memorial Sloan Kettering Cancer Center
Jul 14, 2022

Renal Cell Carcinoma Trial (Pembrolizumab, Axitinib, Sunitinib)

Active, not recruiting
Has Results
  • Renal Cell Carcinoma
  • Pembrolizumab
  • +2 more
  • (no location specified)
Aug 17, 2022

Hepatocellular Carcinoma Trial in Dallas (Axitinib, Avelumab, Bavituximab)

Not yet recruiting
  • Hepatocellular Carcinoma
  • Axitinib
  • +2 more
  • Dallas, Texas
    The University of Texas Southwestern Medical Center
Jun 27, 2022

Advanced Clear Cell Renal Cell Carcinoma Trial in Boston (Axitinib, Palbociclib, Avelumab)

Not yet recruiting
  • Advanced Clear Cell Renal Cell Carcinoma
  • Axitinib
  • +2 more
  • Boston, Massachusetts
  • +2 more
Jun 27, 2022

Non-clear Renal Cell Carcinoma Trial in Nanjing, Nanning (Toripalimab, Axitinib)

Recruiting
  • Non-clear Renal Cell Carcinoma
  • Nanjing, Jiangsu, China
  • +1 more
Mar 13, 2023

Recurrent ACC, metastaticACC, Unreaectable ACC Trial in Seoul (Axitinib, Observation)

Completed
  • Recurrent ACC, metastaticACC, Unreaectable ACC
  • Axitinib
  • Observation
  • Seoul, Korea, Republic of
    Department of Internal Medicine, Seoul National University Hospi
Mar 26, 2022

Advanced Melanoma Trial in China (LBL-007, Toripalimab, Axitinib Tablets)

Recruiting
  • Advanced Melanoma
  • Beijing, Beijing, China
  • +7 more
Jan 9, 2023